In focus · trending topic

dermira

50 stories · following the connections

Newly Published Nonclinical Data Highlight the Role of Olumacostat Glasaretil in Sebum Inhibition

By Nasdaq OMXJun 26, 2017, 11:30 AM UTC

Dermira to Present at Jefferies 2017 Global Healthcare Conference

By Nasdaq OMXMay 30, 2017, 8:08 PM UTC

Dermira to Present at Jefferies 2017 Global Healthcare Conference

By Nasdaq OMXMay 30, 2017, 8:08 PM UTC

Dermira to Present at Jefferies 2017 Global Healthcare Conference

By Nasdaq OMXMay 30, 2017, 8:08 PM UTC

Dermira Announces Closing of 3.00% Convertible Senior Notes Offering

By Nasdaq OMXMay 16, 2017, 8:01 PM UTC

Dermira Prices Offering of $250 Million of 3.00% Convertible Senior Notes

By Nasdaq OMXMay 11, 2017, 1:33 AM UTC

Dermira Announces Proposed Offering of $250 Million of Convertible Senior Notes

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC

Dermira Announces Proposed Offering of $250 Million of Convertible Senior Notes

By Nasdaq OMXMay 9, 2017, 8:05 PM UTC